BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Ganoderma lucidum promotes sleep through a gut microbiota-dependent and serotonin-involved pathway in mice. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 11 Issue 1 Pages: 13660 Pub: 2021 Jul 1 Epub: 2021 Jul 1 Authors Yao C , Wang Z , Jiang H , Yan R , Huang Q , Wang Y , Xie H , Zou Y , Yu Y , Lv L , |
|
|
Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in mice. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 93 Issue Pt A Pages: 904-912 Pub: 2016 Dec Epub: 2016 Sep 9 Authors Li K , Zhuo C , Teng C , Yu S , Wang X , Hu Y , Ren G , Yu M , Qu J , |
|
|
Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in mice. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 93 Issue Pt A Pages: 904-912 Pub: 2016 Dec Epub: 2016 Sep 9 Authors Li K , Zhuo C , Teng C , Yu S , Wang X , Hu Y , Ren G , Yu M , Qu J , |
|
|
Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1362479 Pub: 2024 Epub: 2024 Mar 18 Authors Qin X , Fang Z , Zhang J , Zhao W , Zheng N , Wang X , |
|
|
Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1362479 Pub: 2024 Epub: 2024 Mar 18 Authors Qin X , Fang Z , Zhang J , Zhao W , Zheng N , Wang X , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Ganoderma lucidum Ethanol Extraction Promotes Dextran Sulphate Sodium Induced Colitis Recovery and Modulation in Microbiota. ✅
Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 11 Issue 24 Pages: Pub: 2022 Dec 13 Epub: 2022 Dec 13 Authors Li M , Yu L , Zhai Q , Liu B , Zhao J , Chen W , Tian F , |
|
|
Ganoderma lucidum Ethanol Extraction Promotes Dextran Sulphate Sodium Induced Colitis Recovery and Modulation in Microbiota. ✅
Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 11 Issue 24 Pages: Pub: 2022 Dec 13 Epub: 2022 Dec 13 Authors Li M , Yu L , Zhai Q , Liu B , Zhao J , Chen W , Tian F , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
